345 related articles for article (PubMed ID: 25356037)
21. Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer.
Said N; Najwer I; Motamed K
Am J Pathol; 2007 Mar; 170(3):1054-63. PubMed ID: 17322388
[TBL] [Abstract][Full Text] [Related]
22. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
Puolakkainen PA; Brekken RA; Muneer S; Sage EH
Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
[TBL] [Abstract][Full Text] [Related]
23. Modulation of matrix remodeling by SPARC in neoplastic progression.
Chlenski A; Cohn SL
Semin Cell Dev Biol; 2010 Feb; 21(1):55-65. PubMed ID: 19958839
[TBL] [Abstract][Full Text] [Related]
24. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
Koukourakis MI; Giatromanolaki A; Brekken RA; Sivridis E; Gatter KC; Harris AL; Sage EH
Cancer Res; 2003 Sep; 63(17):5376-80. PubMed ID: 14500371
[TBL] [Abstract][Full Text] [Related]
25. SPARC/osteonectin in mineralized tissue.
Rosset EM; Bradshaw AD
Matrix Biol; 2016; 52-54():78-87. PubMed ID: 26851678
[TBL] [Abstract][Full Text] [Related]
26. SPARC, a matricellular glycoprotein with important biological functions.
Yan Q; Sage EH
J Histochem Cytochem; 1999 Dec; 47(12):1495-506. PubMed ID: 10567433
[TBL] [Abstract][Full Text] [Related]
27. SPARC (osteonectin/BM-40).
Motamed K
Int J Biochem Cell Biol; 1999 Dec; 31(12):1363-6. PubMed ID: 10641790
[TBL] [Abstract][Full Text] [Related]
28. SPARC is associated with gastric cancer progression and poor survival of patients.
Zhao ZS; Wang YY; Chu YQ; Ye ZY; Tao HQ
Clin Cancer Res; 2010 Jan; 16(1):260-8. PubMed ID: 20028745
[TBL] [Abstract][Full Text] [Related]
29. Tumor microenvironment participates in metastasis of pancreatic cancer.
Ren B; Cui M; Yang G; Wang H; Feng M; You L; Zhao Y
Mol Cancer; 2018 Jul; 17(1):108. PubMed ID: 30060755
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic stellate cells derived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECM remodeling in 3D engineered fibrotic tissue of clinically relevant thickness.
Tanaka HY; Kitahara K; Sasaki N; Nakao N; Sato K; Narita H; Shimoda H; Matsusaki M; Nishihara H; Masamune A; Kano MR
Biomaterials; 2019 Feb; 192():355-367. PubMed ID: 30476717
[TBL] [Abstract][Full Text] [Related]
31. Secreted protein acidic and rich in cysteine inhibits the growth of human pancreatic cancer cells with G1 arrest induction.
Mao Z; Ma X; Fan X; Cui L; Zhu T; Qu J; Zhang J; Wang X
Tumour Biol; 2014 Oct; 35(10):10185-93. PubMed ID: 25027401
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cells induce tumor stroma formation and epithelial‑mesenchymal transition through SPARC expression in colorectal cancer.
Naito T; Yuge R; Kitadai Y; Takigawa H; Higashi Y; Kuwai T; Kuraoka K; Tanaka S; Chayama K
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907853
[TBL] [Abstract][Full Text] [Related]
33. Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC.
Arnold S; Mira E; Muneer S; Korpanty G; Beck AW; Holloway SE; Mañes S; Brekken RA
Exp Biol Med (Maywood); 2008 Jul; 233(7):860-73. PubMed ID: 18445772
[TBL] [Abstract][Full Text] [Related]
34. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
[TBL] [Abstract][Full Text] [Related]
35. A peptide of SPARC interferes with the interaction between caspase8 and Bcl2 to resensitize chemoresistant tumors and enhance their regression in vivo.
Rahman M; Chan AP; Tang M; Tai IT
PLoS One; 2011; 6(11):e26390. PubMed ID: 22069448
[TBL] [Abstract][Full Text] [Related]
36. Secreted protein acidic and rich in cysteine antagonizes bufalin-induced apoptosis in gastric cancer cells.
Li A; Qu X; Li Z; Qu J; Song N; Ma Y; Liu Y
Mol Med Rep; 2015 Aug; 12(2):2926-32. PubMed ID: 25936899
[TBL] [Abstract][Full Text] [Related]
37. Diverse biological functions of the SPARC family of proteins.
Bradshaw AD
Int J Biochem Cell Biol; 2012 Mar; 44(3):480-8. PubMed ID: 22249026
[TBL] [Abstract][Full Text] [Related]
38. SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target.
Feng J; Tang L
Curr Pharm Des; 2014; 20(39):6182-90. PubMed ID: 24947586
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder Cancer.
Critselis E; Rava M; Marquez M; Lygirou V; Chatzicharalambous D; Liapi P; Lichtinghagen R; Brand K; Cecchini L; Vlahou A; Malats N; Zoidakis J
Proteomics Clin Appl; 2019 Mar; 13(2):e1800148. PubMed ID: 30632279
[TBL] [Abstract][Full Text] [Related]
40. TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression.
Seux M; Peuget S; Montero MP; Siret C; Rigot V; Clerc P; Gigoux V; Pellegrino E; Pouyet L; N'Guessan P; Garcia S; Dufresne M; Iovanna JL; Carrier A; André F; Dusetti NJ
Oncogene; 2011 Jul; 30(27):3049-61. PubMed ID: 21339733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
